With the development of functional imaging modalities we now have the ability to study the
microenvironment of lung cancer and its genomic instability. Radiomics is defined as the use …

The treatment strategy in advanced non–small cell lung cancer (NSCLC) has evolved from
the use of empirical chemotherapy to a more personalized approach based on histology and …

Tumors are characterized by somatic mutations that drive biological processes ultimately
reflected in tumor phenotype. With regard to radiographic phenotypes, generally …

Objectives To develop and validate a clinical-radiomics nomogram for preoperative
prediction of lung metastasis for colorectal cancer (CRC) patients with indeterminate …

Background Predicting the mutation statuses of 2 essential pathogenic genes [epidermal
growth factor receptor (EGFR) and Kirsten rat sarcoma (KRAS)] in non-small cell lung cancer …

With targeted treatments playing an increasing role in oncology, the need arises for fast non-
invasive genotyping in clinical practice. Radiogenomics is a rapidly evolving field of …

OBJECTIVE. ALK rearrangements are an established targetable oncogenic driver in non–
small cell lung cancer (NSCLC). The goal of this study was to determine the imaging …

Background ROS proto-oncogene 1 (ROS1) rearrangements are a known molecular target
in non–small-cell lung cancer (NSCLC). Our goal was to determine whether ROS1 …

Introduction Several studies have suggested that non–small-cell lung cancer (NSCLC)
patients who harbor anaplastic lymphoma kinase (ALK) rearrangement might have different …

Purpose This study aims to determine if the presence of specific clinical and computed
tomography (CT) patterns are associated with epidermal growth factor receptor (EGFR) …